03-CONTRIBUTO IN RIVISTA
 Distribuzione geografica
Continente #
NA - Nord America 5.260.814
EU - Europa 4.593.018
AS - Asia 2.237.694
SA - Sud America 200.268
AF - Africa 54.199
OC - Oceania 46.757
Continente sconosciuto - Info sul continente non disponibili 5.820
AN - Antartide 1
Totale 12.398.571
Nazione #
US - Stati Uniti d'America 5.133.553
IT - Italia 1.815.409
CN - Cina 917.768
SG - Singapore 610.592
IE - Irlanda 453.952
DE - Germania 397.318
FR - Francia 327.699
SE - Svezia 296.905
FI - Finlandia 223.702
UA - Ucraina 216.945
GB - Regno Unito 196.308
KR - Corea 178.984
DK - Danimarca 132.317
BR - Brasile 125.651
PL - Polonia 116.345
VN - Vietnam 108.372
CA - Canada 85.752
JP - Giappone 78.946
ES - Italia 68.529
IN - India 67.588
NL - Olanda 65.172
ID - Indonesia 63.500
AT - Austria 61.817
HK - Hong Kong 42.959
RU - Federazione Russa 40.303
AU - Australia 40.181
TR - Turchia 38.217
BE - Belgio 34.288
MX - Messico 32.657
CH - Svizzera 29.478
GR - Grecia 24.525
TW - Taiwan 22.462
PT - Portogallo 17.324
CO - Colombia 16.076
PE - Perù 16.065
AR - Argentina 15.698
RO - Romania 15.415
IR - Iran 13.668
PH - Filippine 12.022
CL - Cile 11.617
MY - Malesia 11.259
TH - Thailandia 10.857
PK - Pakistan 10.312
NO - Norvegia 9.645
CZ - Repubblica Ceca 9.164
IL - Israele 9.104
EC - Ecuador 8.504
EG - Egitto 7.922
ZA - Sudafrica 7.861
SA - Arabia Saudita 6.324
HU - Ungheria 6.303
NZ - Nuova Zelanda 6.292
NG - Nigeria 6.074
SN - Senegal 5.925
EU - Europa 4.802
MA - Marocco 4.763
UZ - Uzbekistan 4.479
IQ - Iraq 4.426
LT - Lituania 4.100
HR - Croazia 3.889
RS - Serbia 3.535
BG - Bulgaria 3.458
BD - Bangladesh 3.296
DZ - Algeria 3.265
TN - Tunisia 3.234
SI - Slovenia 3.153
AE - Emirati Arabi Uniti 2.996
SK - Slovacchia (Repubblica Slovacca) 2.819
KE - Kenya 2.812
VE - Venezuela 2.587
JO - Giordania 2.380
MU - Mauritius 2.205
LU - Lussemburgo 1.723
LB - Libano 1.716
UY - Uruguay 1.670
BY - Bielorussia 1.666
CR - Costa Rica 1.652
LV - Lettonia 1.626
EE - Estonia 1.532
KZ - Kazakistan 1.445
LK - Sri Lanka 1.358
AL - Albania 1.354
NP - Nepal 1.325
ET - Etiopia 1.322
CY - Cipro 1.260
BO - Bolivia 1.232
PA - Panama 1.210
BA - Bosnia-Erzegovina 1.065
QA - Qatar 1.051
CI - Costa d'Avorio 1.048
AZ - Azerbaigian 1.032
PY - Paraguay 1.008
GH - Ghana 1.006
MO - Macao, regione amministrativa speciale della Cina 941
PS - Palestinian Territory 864
OM - Oman 836
GT - Guatemala 820
MT - Malta 809
GE - Georgia 759
DO - Repubblica Dominicana 754
Totale 12.377.908
Città #
Santa Clara 605.962
Beijing 543.501
Chandler 451.589
Dublin 446.588
Ann Arbor 413.040
Singapore 313.132
Fairfield 257.225
Houston 253.462
Ashburn 187.181
Torino 181.202
Wilmington 156.180
Villeurbanne 154.205
Jacksonville 148.001
Princeton 144.605
Medford 142.757
Columbus 134.889
Milan 132.941
Woodbridge 127.258
Turin 123.547
Seattle 102.906
Warsaw 98.158
Rome 94.941
Dearborn 88.356
Cambridge 86.598
Pisa 86.113
Nyköping 77.822
Redwood City 76.259
Dong Ket 62.727
Boston 53.822
Jakarta 51.850
Vienna 46.937
Guangzhou 37.185
Helsinki 32.071
Boardman 31.846
Shanghai 30.564
Hangzhou 30.120
Fremont 28.942
Verona 28.254
Toronto 25.624
Nanjing 24.499
Bologna 24.007
Munich 23.838
San Diego 22.968
Norwalk 22.108
Florence 21.451
New York 20.372
Naples 19.782
Frankfurt am Main 19.472
Tokyo 19.454
Brussels 17.740
Hong Kong 17.169
Nuremberg 17.091
London 14.906
Padova 14.547
Hefei 14.366
Los Angeles 13.842
Paris 13.750
Palermo 13.430
Falls Church 13.384
Taipei 12.419
Bari 12.301
Chengdu 12.276
São Paulo 12.225
Ottawa 11.486
Düsseldorf 11.354
Seoul 11.013
Madrid 10.870
Lima 10.698
Athens 10.022
Kunming 9.978
Wuhan 9.885
Phoenix 9.868
Hebei 9.616
Pune 9.606
Lachine 9.460
Mountain View 9.417
Genoa 9.241
Istanbul 9.235
Jinan 9.110
Catania 9.098
Napoli 8.952
Lappeenranta 8.712
Dallas 8.570
Zhengzhou 8.404
Chicago 8.145
Montréal 8.118
Moscow 8.098
Silver Spring 8.096
Washington 7.945
Philadelphia 7.939
Sydney 7.558
Amsterdam 7.555
Berlin 7.303
Santiago 7.298
Barcelona 7.210
San Mateo 6.893
Central District 6.857
Brescia 6.664
Shenyang 6.576
Falkenstein 6.328
Totale 6.828.935
Nome #
Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention 23.591
Lung cancer: current therapies and new targeted treatments 15.585
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. 11.728
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer 10.753
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues 9.142
Diagnosis and treatment of primary aldosteronism 8.699
Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer 8.445
Educación en tiempos de pandemia: reflexiones de alumnos y profesores sobre la enseñanza virtual universitaria en España, Italia y Ecuador 8.384
Amyotrophic lateral sclerosis 8.060
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): And randomised, phase 3, open-label, multicentre study 8.029
Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. 8.015
ESG Sustainability and Financial Capital Structure: Where they Stand Nowadays 7.896
Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis 7.738
Liver cancer: Connections with obesity, fatty liver, and cirrhosis 7.533
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors 6.485
Cryoglobulinaemia 6.391
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors 6.044
Evaluation and treatment of pericarditis: A systematic review 5.913
La cisti ossea aneurismatica: aggiornamento sulla diagnosi, terapia e prognosi 5.853
Nonalcoholic fatty liver disease 5.796
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. 5.689
Il cashgora: evoluzione della produzione e situazione di mercato 5.679
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): A proof-of-concept, multicentre, open-label, phase 2 trial 5.428
High-dose Vitamin C enhances cancer immunotherapy 5.223
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 5.190
Dalla valutazione dello stress lavoro-correlato alla promozione del benessere organizzativo: il caso di una azienda farmaceutica italiana 5.036
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer 5.032
The Linkage between ESG Performance and Credit Ratings: A Firm-Level Perspective Analysis 4.884
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial 4.762
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis 4.546
Interobserver reliability of rheumatologists performing musculoskeletal ultrasonography: results from a EULAR ''Train the trainers'' course 4.361
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR 4.316
State of the art of COVID-19 and business, management, and accounting sector. A bibliometrix analysis. 4.314
Disturbo ossessivo-compulsivo e disturbo schizotipico di personalità: uno studio con la Scala di Bonn per i Sintomi di Base 4.285
Psychometric properties of Short Versions of the Ambivalent Sexism Inventory and Ambivalence Toward Men Inventory 4.265
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. 4.080
Heavy flavour decay muon production at forward rapidity in proton--proton collisions at sqrt(s) = 7 TeV 3.968
A structured therapeutic education program for children and adolescents with type 1 diabetes: an analysis of the efficacy of the "Pediatric Education for Diabetes" project 3.828
Total knee arthroplasty in the varus knee: tips and tricks 3.773
Mediation analysis in epidemiology: methods, interpretation and bias. 3.770
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project 3.745
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component. 3.740
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances 3.591
A physical, genetic and functional sequence assembly of the barley genome. 3.562
First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial. 3.499
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model 3.466
Amyotrophic lateral sclerosis: moving towards a new classification system 3.433
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial 3.221
Gut Microbiota, Immune System, and Bone 3.216
Myths about nutrition in pregnancy 3.150
Il ruolo dell’ambiente nell’apprendimento. L’educazione geografica fra neuroscienze, place-based e outdoor education 3.107
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 3.084
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids 3.056
Alpha-2b recombinant interferon (Intron-A) as maintenance treatment in multiple myeloma. 3.002
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder. 2.985
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer 2.955
Reflection on Coronavirus Accounting Impact on Small and Medium Sized Enterprises (SMEs) in Europe 2.928
Musculoskeletal ultrasound including definitions for ultrasonographic pathology 2.889
Selenium and selenoproteins: an overview on different biological systems 2.877
L'importanza del Progetto Ferri per il "Codice Rocco" 2.800
Effects of time-restricted feeding on body weight and metabolism. A systematic review and meta-analysis 2.799
Cisti aracnoidee del lobo temporale: valutazione neurologica e neuropsicologica pre e post-chirurgica in età evolutiva 2.795
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. 2.782
The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group 2.780
Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation 2.771
PARP Inhibitors in Ovarian Cancer 2.764
Diabetic ketoacidosis with SGLT2 inhibitors 2.754
“Huir de la violencia y construir. Mujeres y desplazamientos en la época de la violencia política en Perú” 2.708
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer 2.655
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice 2.634
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer 2.627
More inequality, fewer class differences: The paradox of attitudes to redistribution across European countries 2.623
Inusuale localizzazione di cisti da inclusione peritoneale 2.577
Is the timing of caloric intake associated with variation in diet-induced thermogenesis and in the metabolic pattern? A randomized cross-over study 2.567
Consensus Paper: Cerebellum and Emotion 2.548
Efficacy of clear aligners in controlling orthodontic tooth movement: A systematic review 2.539
Pericyte Loss in Diabetic Retinopathy: Mechanisms and Consequences 2.522
Levobupivacaina 0,5% isobarica vs bupivacaina 0,5% iperbarica in anestesia spinale nel taglio cesareo (TC): Dati preliminari. 2.515
Vegan-vegetarian diets in pregnancy: Danger or panacea? A systematic narrative review 2.510
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension 2.454
Il benessere organizzativo in sanità: l'esperienza della Regione Piemonte 2.428
Online prosumer convergence: Listening, creating and sharing music on YouTube and TikTok. 2.426
Machine learning for cardiology 2.353
The Dual Roles of NRF2 in Cancer 2.331
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS) 2.326
Individual patient data meta-analysis of folfoxiri plus bevacizumab versus doublets plus bevacizumab as initial therapy of unresectable metastatic colorectal cancer 2.323
The contribution of postural balance analysis in older adult fallers: a narrative review 2.308
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment 2.308
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma. 2.298
Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin? 2.298
Toxicity of neonicotinoid insecticides on different honey bee genotypes 2.279
Good end-of-life care in nursing home according to the family carers’ perspective: A systematic review of qualitative findings 2.277
Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough? 2.267
The Italian five facet mindfulness questionnaire: A contribution to its validity and reliability 2.250
GAPSS: the Global Anti-Phospholipid Syndrome Score. 2.227
Relevance in the Application of IFRS 16 for Financial Statements: Empirical Evidence the Impact of the Financial Method in SMEs 2.210
Lavoro è potere? Segregazione occupazionale e leadership femminile 2.175
The role of microbiota in autism spectrum disorders 2.174
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2.172
Breast cancer treatment in mutation carriers - surgical treatment 2.169
Totale 435.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020337.282 0 0 0 0 0 0 0 0 0 128.839 124.604 83.839
2020/20211.370.752 95.465 73.893 114.152 86.841 118.565 97.057 122.629 75.457 153.104 131.808 99.561 202.220
2021/20221.587.779 86.321 97.513 103.194 134.970 105.681 88.315 123.947 115.072 87.504 107.625 218.975 318.662
2022/20231.919.879 204.402 110.418 61.525 147.555 177.335 468.638 196.349 128.588 185.492 58.839 108.869 71.869
2023/20241.167.688 119.642 147.762 74.236 84.129 88.529 108.715 71.552 80.328 22.171 92.496 106.314 171.814
2024/20252.321.331 68.256 198.041 144.217 270.948 771.268 237.211 126.810 176.626 318.281 9.673 0 0
Totale 12.841.496